REMINDER: Our user survey closes on Friday, please submit your responses here.
https://twitter.com/bdfne/status/1640070784319094784
Rudaw claims Baghdad and Erbil have agreed oil exports through Cayhan will resume "in a day or two" with KRG continuing to sell its oil until federal budget law is passed, then the mechanisms set within budget law will be used to resolve this issue.
That's total garbage Armas - this has been in the courts for months. A resolution will be found. Expect shares to be suspended tomorrow - too much at stake and going on to allow orderly trading.
Definitely not good however there's a large cash element to GENL's market cap so one would think some downside protection.
Puts pressure on board and **probably** draw a bit of a line in sand on share price decline.
We shouldn't forget the market cap isn't a few million of even tens of millions it's £130m
They've already indicated Sales wouldn't start into Q2 so no panic yet. Not that the market believes it.
Very odd - I checked the announcement a few times but no news in there so I also would query the timing....tick tock....
WTP,
You've understood me incorrectly then. The update is incredibly positive but it is only one patient.
Sure - I'm aware of that - that doesn't however mean everything else they post is correct and perhaps more pertinent they have always interpreted correctly. Hence why as Bermuda notes we should only trust RNS publications.
And perhaps more importantly no-one other than the poster knows whether what they are posting is accurate.
I'm not suggesting this is the case but anyone could post on that forum and we'd have no idea of its veracity.
As soon as someone posts publicly their right to anonymity and keeping something in their private business is gone. Simple point but reality.
Agreed - very positive - but some posters seem to be getting ahead of themselves as always.
Only "news" is that we only had the stable definition previously - not "going in right direction"
All companies start off small - even the likes of Pfizer and AstraZeneca had to start from somewhere!
Thanks for that - missed the obvious but still nice to see some PR
First time I've seen outside of US hospitals mention of Xenon 129 - https://www.linkedin.com/feed/update/urn:li:activity:7038796025066614784/
Amazing what happens when sentiment is rock bottom. Market cap now £45m which includes £12m of cash to last until May 2024. It's getting to the stage of very high reward for little risk.
Budget changes to MHRA regulatory regime from 2024 to give much-faster approvals on innovative medical treatments and drugs - one would think Polarean's US FDA approval can be approved in UK quite quickly.
They could probably get 50p at a push. It is indeed disappointing particularly when you consider on 28th December it hit 80p and since then excepting a c.$2.5m reduction in cash everything else is on track and HW was obtained.
Not unusual at all. MM's have an amount they are willing to let go at certain prices. Just because the offer shows at 16p doesn't mean you can have any at that price.